XYJ-31445-96269
5 vaccinations
9 coded responses
23 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 207 / MD
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-02-22
Registered in v-safe
-
2021-02-22
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Injection site erythema, Injection site swelling, Joint stiffness, Musculoskeletal stiffness, Pain in extremity, Somnolence — Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-23
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Pain in extremity — Feeling: Good · Site: Pain · Muscle or body achesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-08-21
-
2021-12-17
Dose 3 — Pfizer-BioNTech
- 2022-02-22
-
2022-03-18
Survey response — 3 month, dose 3MedDRA: Sluggishness, Somnolence — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2022-05-05
Dose 4 — Moderna
-
2022-05-06
Survey response — days 1–6 daily, dose 4MedDRA: Cold sweat — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2022-05-07
Survey response — days 1–6 daily, dose 4MedDRA: Frequent bowel movements — Feeling: Good · Site: PainMedDRA releases: 2024-11 · check-in answers available
-
2022-05-08
Survey response — days 1–6 daily, dose 4MedDRA: No adverse event — Feeling: Good · Site: PainMedDRA releases: 2024-11 · check-in answers available
-
2022-05-09
Survey response — days 1–6 daily, dose 4MedDRA: No adverse event — Feeling: Good · HeadacheMedDRA releases: 2024-11 · check-in answers available
-
2022-05-10
Survey response — days 1–6 daily, dose 4MedDRA: Unevaluable event — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2022-05-11
Survey response — days 1–6 daily, dose 4MedDRA: Diarrhoea — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
- 2022-05-12
- 2022-05-19
- 2022-05-26
- 2022-06-02
- 2022-06-09
- 2022-06-16
-
2023-01-30
Dose 5 — Pfizer-BioNTech
- 2023-05-05
- 2023-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
| 4 | 2022-05-05 | Moderna | No |
| 5 | 2023-01-30 | Pfizer-BioNTech | No |
Free text
Release 4
Systemic reaction (other): Also redness and swelling at injection site. All of these symptoms were with my 1st vaccine for abt 3-4 days; but only tiredness/sleepiness, stiff and sore arm are all that I have felt with the second.
Systemic reaction (other): Some soreness in my arm
Release 11
Symptoms: I have been feeling sluggish and sleepy of late. Not at all sure if DST has anything to do with it, but thought I should mention.
Systemic reaction (other): Cold sweats
Systemic reaction (other): In addition to the symptoms I reported yesterday, 5/6, I had 3 BMs in less than 12hrs.
Systemic reaction (other): None
Systemic reaction (other): No
Systemic reaction (other): Feeling real good today
Systemic reaction (other): Not diarrhea, but have had 3 separate loose bowel movements so far today. Uncertain whether it has stopped. Drinking plenty of water!
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sluggishness | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SRO | Cold sweat | · | · | ✓ |
| SRO | Diarrhoea | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Frequent bowel movements | · | · | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Joint stiffness | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Somnolence | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release